2023 GOLD Report for Chronic Obstructive Pulmonary Disease
Dr. Antonio Anzueto, Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the University of Texas Health San Antonio, discusses the 2023 Global Obstruction Lung Disease (GOLD) Report that recommends long-acting muscarinic antagonist (LAMA), long-acting beta agonist (LABA), or LAMA+LABA therapy as a first-line treatment for most patients with COPD, regardless of exacerbation risk.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Therapy. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Therapy and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Therapy?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Dr. Antonio Anzueto is a Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the University of Texas Health San Antonio and specializes in Pulmonary Medicine and Critical Care.
He completed his undergraduate studies at Colegio Liceo Javier in 1972. He received his Doctor of Medicine in 1979 at the University of San Carlos, in Guatemala City. In 1989, he completed his internship and residency in internal medicine followed by Pulmonary Medicine/ Critical Fellowship at University of Texas, Health, San Antonio.
He is an active member of the American Thoracic Society, American College of Chest Physicians (CHEST), European Respiratory Society, Latin American Thoracic Society (ALAT), Global Obstruction Lung Disease (GOLD).
Dr. Anzueto and his Pulmonary research group are currently conducting clinical studies that involve treating conditions that range from chronic obstructive pulmonary disease (COPD), pneumonia, acute respiratory distress/injury, to septic shock.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
